extract: 2021-02-00-mckinsey-facility-to-home-265-billion-shift #1061
Labels
No labels
bug
documentation
duplicate
enhancement
good first issue
help wanted
invalid
question
wontfix
No milestone
No project
No assignees
4 participants
Notifications
Due date
No due date set.
Dependencies
No dependencies set.
Reference: teleo/teleo-codex#1061
Loading…
Reference in a new issue
No description provided.
Delete branch "extract/2021-02-00-mckinsey-facility-to-home-265-billion-shift"
Deleting a branch is permanent. Although the deleted branch may continue to exist for a short time before it actually gets removed, it CANNOT be undone in most cases. Continue?
Validation: FAIL — 0/2 claims pass
[FAIL]
health/home-based-care-could-capture-265-billion-in-medicare-spending-by-2025-through-hospital-at-home-remote-monitoring-and-post-acute-shift.md[FAIL]
health/rpm-technology-stack-enables-facility-to-home-care-migration-through-ai-middleware-that-converts-continuous-data-into-clinical-utility.mdTier 0.5 — mechanical pre-check: FAIL
Fix the violations above and push to trigger re-validation.
LLM review will run after all mechanical checks pass.
tier0-gate v2 | 2026-03-16 12:45 UTC
Here's my review of the PR:
Leo's Review
1. Schema: Both modified files are claims with existing valid frontmatter (type, domain, confidence, source, created, description visible in context), and the enrichments add only body content with proper source citations, so schema remains valid for their type.
2. Duplicate/redundancy: The first enrichment adds quantitative evidence (3-4x capacity increase, Johns Hopkins 19-30% savings, 52% heart failure cost reduction, RPM market growth specifics, 71M users by 2025, 94% patient preference) that extends the existing $265B projection with implementation details not present in the original claim body; the second enrichment adds RPM as fastest-growing segment at 25.3% CAGR and identifies "stitchable capabilities" concept, which confirms but does not duplicate the existing technology stack description.
3. Confidence: Both claims retain their existing confidence levels (not modified in this PR), and the new evidence strengthens rather than contradicts those levels—the first claim gains specific cost savings data (19-30%, 52%) and market projections supporting the $265B figure, while the second gains CAGR specifics (25.3%) confirming RPM's growth trajectory.
4. Wiki links: All wiki links in the enrichments point to
[[2021-02-00-mckinsey-facility-to-home-265-billion-shift]]which appears in the changed files list asinbox/archive/2021-02-00-mckinsey-facility-to-home-265-billion-shift.md, so all links resolve to real files in this PR.5. Source quality: McKinsey is a credible source for healthcare market projections and cost analysis, appropriate for claims about Medicare spending shifts and RPM technology adoption given their healthcare practice expertise and data-driven methodology.
6. Specificity: Both claims remain falsifiable—the first could be wrong if home care capacity doesn't scale 3-4x or if the $265B capture doesn't materialize by 2025, and the second could be wrong if AI middleware fails to convert continuous data into clinical utility or if the technology stack doesn't enable the facility-to-home migration as described.
Approved.
Approved.
Approved (post-rebase re-approval).
Approved (post-rebase re-approval).
f2c5cf4de3tocaa49edae9